From Breakthroughs Blog: Congress

 
Flickr/Craig Fildes
Democrats take the House and Republicans maintain hold on the Senate in midterm elections

While the dust is still settling from the US midterm elections, the major takeaways are set: Democrats have taken the House and Republicans have solidified their hold in the Senate. This means a shake up in leadership and the make-up of key Congressional committees. GHTC takes a look at what these changes could mean for continued US support for global health R&D.

Read More
PATH/Patrick McKern
The post-midterm prognosis for global health R&D

With less than two weeks to go until one of the most anticipated midterm elections in recent memory, there are big questions occupying the minds of Washingtonians and politics junkies from coast to coast.

Read More
Sanofi Pasteur / Patrick Boulen
A year in review: The global health innovation stories that shaped 2017

As the year comes to an end, GHTC is reflecting on the top stories in global health innovation that made news in 2017.

Read More
Architect of the Capitol
Global health and medical research saved from spending cuts in FY17 budget agreement

What global health R&D advocates need to know about the FY2017 budget agreement.

Read More
GHTC/Marissa Chmiola
Global health R&D gamified!

We ate, we drank, we played games, and we learned a thing or two about the impact of US leadership in global health R&D.

Read More
CDC/Sue Partridge, CDC- Ft. Collins
Twenty six current and past ASTMH presidents call for Congress to act on Zika funding

Twenty six current and past presidents of the American Society of Tropical Medicine and Hygiene sent a letter urging Congress to pass an emergency spending bill to combat the Zika virus as soon as possible.

Read More
Obama highlights global health and innovation in State of the Union

GHTC has long championed US leadership in global health and innovation, and we were encouraged to see President Barack Obama highlight these themes in his State of the Union address.

Read More
PATH/Nguyen Ba Quang
Research Roundup: Middle East Respiratory Syndrome R&D, G7 support for antimicrobial and neglected tropical disease R&D, patient safety and the 21st Century Cures Act, and the contraceptive pipeline

The zoonotic Middle East Respiratory Syndrome (MERS), which World Health Organization (WHO) Director-General Dr. Margaret Chan called “a threat to the entire world” has spread to South Korea. More than 100 cases and 10 deaths have been reported, making it the largest outbreak outside of the Arabian Peninsula.

Read More
Research Roundup: priority review voucher sells for record price, WHO action to address antimicrobial resistance, and more

The French pharmaceutical company Sanofi purchased a priority review voucher (PRV)—which entitles the owner to an expedited review of a future product by the US Food and Drug Administration (FDA)—for US$245 million last week.

Read More
21st Century Cures Act: What the global health community needs to know

Last week, the House Energy and Commerce Committee unanimously voted to approve the 21st Century Cures Act—a bill that aims to speed the development, approval, and introduction of new health technologies.

Read More
CDC/Melissa Dankel
Research Roundup: US and European efforts to address growing antimicrobial resistance and legislation to advance medical breakthroughs

Members of the European Parliament are calling on the European Commission to adopt a resolution to combat the growing threat of antimicrobial resistance—which kills 25,000 Europeans annually.

Read More
Will Boase
Research Roundup: inclusion of women in clinical trials, the future of vaccines, and diagnostics for counterfeit medicines and parasitic worms

United States Representatives Jim Cooper (D-TN) and Cynthia Loomis (R-WO) introduced the Research for All Act last week which calls for the inclusion of more women in clinical trials for products submitted for US Food and Drug Administration (FDA) approval.

Read More
PATH/Evelyn Hockstein
GHTC briefing highlights importance of global health innovation in protecting US and world from threats like Ebola

On Thursday, March 26, 2015, the Global Health Technologies Coalition (GHTC) launched its sixth annual policy report titled Meeting the challenge, seizing the opportunity: US leadership can advance global health R&D with a luncheon and panel discussion on Capitol Hill.

Read More
PATH/Patrick McKern
Research Roundup: Progress towards a vaccine for HIV, a rapid diagnostic and experimental drug for Ebola, and congressional support for global health research

A new compound has successfully protected monkeys from HIV, according to a study published in Nature last week.

Read More
How the upcoming election could impact global health R&D

As candidates make their final pitches, volunteers canvas like crazy, and pollsters make their predictions, GHTC is taking a look at what the outcomes of next week’s election could mean for global health research and development (R&D).

GHTC
Read More
Recess is over: What Congress should act on now

After a five week recess, members of Congress returned to their Capitol Hill offices on Tuesday night.

GHTC
Read More
Research Roundup: Appropriations, Ebola, AIDS 2014, open working groups, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Will Boase
Research Roundup: EDCTP Forum, Sayana® Press, a new dengue vaccine, the 21st Century Cures Initiative, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Robin Biellik
Research Roundup: SFOPS, new FDA guidance, top trends in global health, new report on global health R&D, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
House and Senate support global health R&D in appropriations reports

While lawmakers battled it out on the field last week during the annual Congressional Baseball Game (Democrats won for the sixth year in a row!), they found something they could join together on as the House Appropriations Committee easily approved the State and Foreign Operations Subcommittee’s (SFOPS) appropriations bill on Tuesday afternoon.

GHTC
Read More
NIAID
Research Roundup: FY 2015 appropriations, the Human Vaccines Project, Global Development Lab legislation, new HIV treatments, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Research Roundup: New drugs against diarrhea, the End Neglected Tropical Diseases Act, genetically-modified mosquitoes, and mines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Impact of PCAST recommendations on advancing global health R&D

Recently, there has been a surge of interest in evaluating progress made on the 2012 President’s Council of Advisors on Science and Technology’s (PCAST) recommendations that aim to accelerate research and development (R&D) of new therapeutics.

GHTC
Read More
Architect of the Capitol
Global health technology legislation introduced in Senate and what that means

The global health research community has a reason to celebrate this weekend. Yesterday, Senator Patty Murray (D-WA) introduced in the US Senate a significant piece of global health legislation that would strengthen global health research programming within the US Agency for International Development (USAID) and improve coordination of global health research and development (R&D) across the US government.

Read More
PATH/Evelyn Hockstein
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
GHTC
GHTC briefing highlights role of US leadership in global health R&D

“I deeply believe in the importance, power, and influence of research,” said Senator Chris Coons (D-DE) at GHTC’s congressional briefing.

GHTC
Read More
What we’re looking forward to in 2014

As 2014 gets into full swing, the GHTC is looking ahead to many exciting developments on both the global health research and development (R&D) and policy landscapes:

GHTC
Read More
The role of HIV research in ending AIDS: New developments in HIV vaccine and prevention science

In this guest post, Emily Donaldson—program coordinator at AVAC: Global Advocacy for HIV Prevention—writes about an upcoming congressional briefing on November 18 that will highlight the latest in HIV/AIDS research and development.

AVAC
Read More
No more business as usual: USAID’s important role in global health R&D highlighted at Capitol Hill briefing

“You’re in a position to make such a difference and to be innovative with your thinking,” Margaret McCluskey, senior technical advisor at the US Agency for International Development (USAID), said to an audience of Congressional staffers at a briefing yesterday on Capitol Hill.

GHTC
Read More
What’s ahead on the Hill: An update on the government shutdown and global health R&D programs

In this guest post, Jenny Howell—senior policy & advocacy associate at PATH working with the GHTC—writes about how the government shutdown and budget negotiations in Congress will impact global health research and development (R&D) programs across the federal government.

GHTC
Read More
New GHTC resources highlight FDA’s critical role in global health

The GHTC has long stressed that the US Food and Drug Administration (FDA) plays a critical part in efforts to improve global public health.

GHTC
Read More
What’s ahead on the Hill: The top five priorities for Congress before the end of 2013

Now that Labor Day has passed and Washington, DC, is starting to cool down, members of Congress are filtering back into town from their August recess travels.

GHTC
Read More
House subcommittee bill would cut global health and international development programs

The House State and Foreign Operations (SFOPS) Appropriations Subcommittee on Friday held a hearing on its fiscal year (FY) 2014 budget legislation.

GHTC
Read More
What’s Ahead on the Hill: New bill would improve transparency of US foreign aid programs

Last week, a bipartisan group of legislators in both the House and Senate introduced the Foreign Aid Transparency and Accountability Act of 2013.

GHTC
Read More
What’s ahead on the Hill: Congress moving slowly on a federal budget deal

Congress is heading for its July 4 recess next week, having made a few incremental steps toward a fiscal year (FY) 2014 budget for the federal government—including releasing spending levels for several agencies and programs that support global health and research efforts.

GHTC
Read More
Improving US programs for the world’s most neglected patients

“A small, modest investment from the US government could truly transform the lives of people around the world and make a serious public health impact,” Rachel Cohen from the Drugs for Neglected Diseases initiative said yesterday at a congressional briefing focused on neglected tropical diseases (NTDs).

GHTC
Read More
New bill would prompt welcome reforms to US foreign assistance programs, including global health R&D

Last week, Reps. Gerry Connolly (D-VA), Karen Bass (D-CA), and Earl Blumenauer (D-OR) introduced the Global Partnerships Act of 2013.

GHTC
Read More
New bill would bolster USAID’s role in global health research

Earlier this month, Reps. Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) introduced the 21st Century Global Health Technology Act, which would make several important and welcome changes to global health research and development (R&D) programs at the US Agency for International Development (USAID).

GHTC
Read More
The Rally for Medical Research: Protecting investments in tropical medicine and global health science

In this guest post, Karen A. Goraleski, executive director of the American Society of Tropical Medicine and Hygiene, writes about the importance of US funding for global health research. This is the third post in a series about this week’s Rally for Medical Research.

Read More
Rally for medical research: Building a grassroots movement to make medical research a higher national priority

In this guest post, Megan Kane, PhD, communications intern, and Morgan McCloskey, global health intern, from Research!America write about a rally earlier this week in support for health science and research.

Research!America
Research!America
Read More
Rally ‘round the research

In this guest post, Regina McEnery—science writer for IAVI Report and VAX—writes about a rally held in Washington, DC, on April 8 to call on federal policymakers to support health research. This post originally appeared on the IAVI Report blog.

IAVI Report and VAX
Read More
Budget update: Congress passes budget package for FY2013, while House and Senate introduce starkly different FY2014 budget proposals

Earlier this week, both the House and Senate passed a budget package to fund the government through the remainder of fiscal year (FY) 2013, thereby averting a government shutdown when current funding expires on March 27.

GHTC
Read More
PATH
GHTC members urge Congress to protect global health research funding

Earlier this week, the GHTC and other global health and international development advocates called on the House Appropriations State and Foreign Operations subcommittee to fully fund key programs in the foreign affairs budget.

GHTC
Read More
Architect of the Capitol
GHTC 2013 report: Clear steps for policymakers to renew the US legacy in global health R&D

We have long known that Washington is operating under a remarkably unorthodox budgetary process.

GHTC
Read More
A chorus of voices across the government calls for a solution to sequestration

During last week’s State of the Union address, President Obama called on policymakers to find a solution to the federal budget debate before sequestration—or widespread and indiscriminate cuts to all federal programs—takes place next month.

GHTC
Read More
Obama begins second term with new faces, changing leadership in key global health positions

President Obama officially began his second term in office this week, and will have a host of new faces to work with in Congress and his own administration.

GHTC
Read More
Halting the fiscal cliff: How will the latest budget negotiations impact global health and development?

Going into December 2012, Congress had neither completed its work on the federal budget for fiscal year (FY) 2013 nor decided how to avoid sequestration—widespread and indiscriminate cuts to all federal programs.

GHTC
Read More